Search Results - Xuening Li
- Showing 1 - 7 results of 7
-
1
Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling by Ruifang Guan, Ruifang Guan, Xuening Li, Guo Ma
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Maternal dietary patterns during pregnancy and the risk of infantile eczema during the first year of life: a cohort study in northeast China by Xuening Li, Zhe Xiao, Chenyang Li, Qi Chen, Lihong Jia
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Efficacy and safety of tirzepatide in patients with type 2 diabetes mellitus: A bayesian network meta-analysis by Ruifang Guan, Ruifang Guan, Qing Yang, Xiaolei Yang, Wandi Du, Xuening Li, Guo Ma
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of CMAB807, a New Denosumab Biosimilar, in Healthy Chinese Subjects by Hanjing Chen, Weili Chen, Fei Yuan, Qingcheng Guo, Xunmin Zhang, Chenguang Wang, Xuening Li
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials by Yanli Sun, Yanli Sun, Jie Han, Zhanzhao Wang, Xuening Li, Yanhua Sun, Zhenbo Hu, Zhenbo Hu
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Evaluating the bioequivalence and safety of liraglutide injection versus Victoza® in healthy Chinese subjects: a randomized, open, two-cycle, self-crossover phase I clinical trial by Chao Liu, Hongrong Xu, Fei Yuan, Hanjing Chen, Lei Sheng, Weili Chen, Haisong Xie, Hongmei Xu, Xuening Li
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Risk assessment and molecular mechanism study of drug-drug interactions between rivaroxaban and tyrosine kinase inhibitors mediated by CYP2J2/3A4 and BCRP/P-gp by Tingting Zhao, Xuening Li, Yanwei Chen, Jie Du, Xiaodong Chen, Dalong Wang, Liyan Wang, Shan Zhao, Changyuan Wang, Changyuan Wang, Qiang Meng, Qiang Meng, Huijun Sun, Huijun Sun, Kexin Liu, Kexin Liu, Jingjing Wu, Jingjing Wu
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book